Organon (MEX:OGN) Ending Cash Position : MXN14,078 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Organon Ending Cash Position?

Organon's Ending Cash Position for the quarter that ended in Dec. 2024 was MXN14,078 Mil.

Organon's quarterly Ending Cash Position increased from Jun. 2024 (MXN12,897 Mil) to Sep. 2024 (MXN15,024 Mil) but then declined from Sep. 2024 (MXN15,024 Mil) to Dec. 2024 (MXN14,078 Mil).

Organon's annual Ending Cash Position declined from Dec. 2022 (MXN13,764 Mil) to Dec. 2023 (MXN11,763 Mil) but then increased from Dec. 2023 (MXN11,763 Mil) to Dec. 2024 (MXN14,078 Mil).

Organon Ending Cash Position Historical Data

The historical data trend for Organon's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organon Ending Cash Position Chart

Organon Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

238.70

15,118.82

13,764.18

11,763.15

14,077.60

Organon Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Ending Cash Position	Get a 7-Day Free Trial															11,763.15	9,542.85	12,897.35	15,023.70	14,077.60

Organon Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Organon's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	14453	+	-375.403
	=	14,078

Organon's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	15912.898	+	-1835.301
	=	14,078

Organon Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Organon's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Organon Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organon & Co (MEX:OGN) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

OGN:USA 1OGN:Italy 0A9W:UK 7XP:Germany

Address

30 Hudson Street, Floor 33, Jersey City, NJ, USA, 07302

Website

https://www.organon.com

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.